JPRN-UMIN000011461已完成未知
An open label, single institute, single arm trial of efficacy and safety of the anti-RANKL monoclonal antibody (Denosumab) for patients with steroid-induced osteoporosis - OSRANKLE-SIO study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Cancer patients with bone metastasis or expected bone metastasis 2)Hypocalcemia 3)Women who wish to be pregnant or are pregnant, or in lactation 4)Hypersensitivity to the denosumab 5)Cancer patients on cancer treatment or anti-hormonal therapy 6)Dental therapy during this trial 7)Long term use of bisphosphonate and have atypical fracture 8)Severe skin infection
研究者
相似试验
已完成
不适用
A single centre, open label trial investigating the absorption, metabolism and excretion of somapacitan after single subcutaneous dosing in healthy male subjectsgroeihormoondeficientiegrowth hormone deficiencyNL-OMON42854ovo Nordisk A/S7
已完成
不适用
A pilot study to evaluate the safety and advantages of CurQfen on brain function in middle aged to elderly people.CTRI/2018/03/012393Akay Flavours and Aromatics Private Limited6
进行中（未招募）
不适用
Medical research trial for testing drug treatment of alpha-Mannosidosisalpha-MannosidosisMedDRA version: 17.1Level: LLTClassification code 10032658Term: Other specified disorders of carbohydrate transport and metabolismSystem Organ Class: 100000004850EUCTR2014-003950-15-DKZymenex A/S
进行中（未招募）
1 期
Clinical study of CV-HFG01 Tablets in management of Hyperuricemia and associated pain in gout.CTRI/2019/04/018495Climic Health Pvt Ltd
进行中（未招募）
1 期
Clinical study to assess the usefulness of CV-HFU01 tablets in management of recurrent UTI.CTRI/2019/04/018452Climic Health Pvt Ltd